Abiopharma

🔍 Ibrahim Christina M (Executive)

Company: FLOTEK INDUSTRIES INC/CN/ (FTK)

Report Date: 2026-03-02

Detailed Transactions and Holdings:

• Acquired 3,163 shares of Common Shares (Direct)
  Date: 2026-03-02 | Code: A | equity_swap_involved: 0 | shares_owned_after: 3,163.00 | transaction_form_type: 4 | Footnotes: F1
• Acquired 8,357 shares of Common Shares (Direct)
  Date: 2026-03-10 | Code: A | equity_swap_involved: 0 | shares_owned_after: 11,520.00 | transaction_form_type: 4 | Footnotes: F1
• Acquired 8,357 shares of Performance Based Restricted Stock Unit (Derivative)
  Date: 2026-03-10 | Code: A | equity_swap_involved: 0 | shares_owned_after: 8,357.00 | transaction_form_type: 4 | Footnotes: F2, F2, F2

Footnotes:

• F1: Restricted stock units that vest in three equal annual installments.
• F2: Each Performance Based Restricted Stock Unit ("PRSU") represents a contingent right to receive one share of Flotek Industries, Inc. common stock, subject to the following conditions. Up to half of the PRSUs will vest if, and to the extent, the Company's Adjusted EBITDA meets or exceeds certain thresholds during the performance period of January 1, 2026 to December 31, 2027, subject to continued employment through December 31, 2028. Up to half of the PRSUs will vest, if, and to the extent, the company's total shareholder return relative to the Russell 2000 Index-Oil Equipment and Services, measured over a performance period from January 1, 2026 through December 31, 2028, meets or exceeds certain thresholds.